INM (InMed Pharmaceuticals Inc. Common Shares) Stock Analysis - Community
InMed Pharmaceuticals Inc. Common Shares (INM) is a publicly traded Healthcare sector company. As of May 19, 2026, INM trades at $1.42 with a market cap of $2.12M and a P/E ratio of -0.08. INM moved +125.50% today. Year to date, INM is -39.22%; over the trailing twelve months it is -76.93%. Its 52-week range spans $0.58 to $8.27. Rallies surfaces INM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
How does the Rallies community trade INM?
Rallies community data for INM shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
MANCINI ALEXANDRA DIANE JANET sold 240 (~$42.312) on Jul 31, 2024.
HULL ANDREW bought 37.50K (~$14.63K) on Feb 21, 2024.
ADAMS ERIC A bought 41.60K (~$14.92K) on Feb 20, 2024.
INM Analyst Consensus
INM analyst coverage data. Average price target: $0.00.
Common questions about INM
How does the Rallies community trade INM?
Rallies community data for INM shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Does Rallies show retail investor data for INM?
Rallies shows anonymized community ownership, retail positioning, sentiment, and portfolio context for INM when enough community data is available.
Is INM research on Rallies investment advice?
No. Rallies provides research, data, and educational context for INM. It does not provide personalized investment advice.